A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer

References

• Sudhindra A, Ochoa R, Santos, ES. Biomarkers, prediction, and prognosis in non-small-cell lung cancer: a platform for personalized treatment. Clin Lung Cancer 2011;12:360–368. doi:10.1016/j.cllc.2011.02.003. PMID:21729648.
   PubMed Web of Science ®Google Scholar
• Carnio S, Novello S, Mele T, Levra MG, Scagliotti GV. Extending survival of stage IV non-small cell lung cancer. Semin Oncol 2014;41:69–92. doi:10.1053/j.seminoncol.2013.12.013. PMID:24565582.
   PubMed Web of Science ®Google Scholar
• Palma DA, Warner A, Louie AV, Senan S, Slotman B, Rodrigues GB. Thoracic radiotherapy for extensive stage small-cell lung cancer: a meta-analysis. Clin Lung Cancer 2016;17:239–244. doi:10.1016/j.cllc.2015.09.007. PMID:26498503.
   PubMed Web of Science ®Google Scholar
• Nieder C, Norum J. Palliative radiotherapy in patients with metastatic non-small cell lung cancer. Ann Palliat Med 2013;2:51–53. PMID:25841747.
   PubMedGoogle Scholar
• Chen AB, Cronin A, Weeks JC, Chrischilles EA, Malin J, Hayman JA, Schrag D. Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) study. J Clin Oncol 2013;31:558–564. doi:10.1200/JCO.2012.43.7954. PMID:23295799.
   PubMed Web of Science ®Google Scholar
• Temel JS, McCannon J, Greer JA, Jackson VA, Ostler P, Pirl WF, Lynch TJ, Billings JA. Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer 2008;113:826–833. doi:10.1002/cncr.23620. PMID:18618579.
   PubMed Web of Science ®Google Scholar
• Koshy M, Malik R, Mahmood U, Husain Z, Weichselbaum RR, Sher DJ. Prevalence and predictors of inappropriate delivery of palliative thoracic radiotherapy for metastatic lung cancer. J Natl Cancer Inst 2015;107:djv278. doi:10.1093/jnci/djv278. PMID:26424779.
   PubMedGoogle Scholar
• Fairchild A, Harris K, Barnes E, Wong R, Lutz S, Bezjak A, Cheung P, Chow E. Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 2008;26:4001–4011. doi:10.1200/JCO.2007.15.3312. PMID:18711191.
   PubMed Web of Science ®Google Scholar
• Vinod SK. Decision making in lung cancer – how applicable are the guidelines? Clin Oncol (R Coll Radiol) 2015;27:125–131. doi:10.1016/j.clon.2014.10.008. PMID:25467071.
   PubMed Web of Science ®Google Scholar
• Nieder C, Bremnes RM, Andratschke NH. Prognostic scores in patients with brain metastases from non-small cell lung cancer. J Thorac Oncol 2009;4:1337–1341. doi:10.1097/JTO.0b013e3181b6b6f4. PMID:19701108.
   PubMed Web of Science ®Google Scholar
• Rades D, Käsmann L, Schild SE, Janssen S. A survival score for patients receiving palliative irradiation for locally advanced lung cancer. Clin Lung Cancer 2016;17:558–562. doi:10.1016/j.cllc.2016.05.010. PMID:27341791.
   PubMed Web of Science ®Google Scholar
• Nieder C, Tollåli T, Haukland E, Reigstad A, Flatøy LR, Dalhaug A. External validation of a prognostic score for patients receiving palliative thoracic radiotherapy for lung cancer. Clin Lung Cancer 2017;18:e297–e301. pii: S1525-7304(17)30021-9. doi:10.1016/j.cllc.2017.01.006.
   PubMedGoogle Scholar
• Giroux Leprieur E, Lavole A, Ruppert AM, Gounant V, Wislez M, Cadranel J, Milleron B. Factors associated with long-term survival of patients with advanced non-small cell lung cancer. Respirology 2012;17:134–142. doi:10.1111/j.1440-1843.2011.02070.x. PMID:21943088.
   PubMed Web of Science ®Google Scholar
• Bremnes RM, Sundstrom S, Aasebø U, Kaasa S, Hatlevoll R, Aamdal S, Norwegian Lung Cancer Study Group. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer 2003;39:303–313. doi:10.1016/S0169-5002(02)00508-1. PMID:12609569.
   PubMed Web of Science ®Google Scholar
• Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C. C-reactive protein is an important biomarker for prognosis, tumor recurrence and treatment response in adult solid tumors: a systematic review. PLoS One 2015;10:e0143080. doi:10.1371/journal.pone.0143080. PMID:26717416.
   PubMed Web of Science ®Google Scholar
• Nieder C, Mannsåker B, Dalhaug A, Pawinski A, Haukland E. Palliative radiotherapy in cancer patients with increased serum C-reactive protein level. In Vivo 2016;30:581–586. PMID:27566075.
   PubMed Web of Science ®Google Scholar
• Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, et al. Extended survival and prognostic factors for patients with ALK-rearranged non-small-cell lung cancer and brain metastasis. J Clin Oncol 2016;34:123–129. doi:10.1200/JCO.2015.62.0138. PMID:26438117.
   PubMed Web of Science ®Google Scholar
• Raskin W, Harle I, Hopman WM, Booth CM. Prognosis, treatment benefit and goals of care: what do oncologists discuss with patients who have incurable cancer? Clin Oncol (R Coll Radiol) 2016;28:209–214. doi:10.1016/j.clon.2015.11.011. PMID:26698027.
   PubMed Web of Science ®Google Scholar
• Mulvenna P., Nankivell, M., Barton, R., Faivre-Finn, C., Wilson, P., McColl, E., Moore B, Brisbane I, Ardron D, Holt T, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet 2016;388:2004–2014. doi:10.1016/S0140-6736(16)30825-X. PMID:27604504.
   PubMed Web of Science ®Google Scholar
• Gomez DR, Blumenschein GR Jr, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 2016;17:1672–1682. doi:10.1016/S1470-2045(16)30532-0. PMID:27789196.
   PubMed Web of Science ®Google Scholar
• Nieder C, Tollåli T, Reigstad A, Pawinski A, Haukland E, Dalhaug A. Oligometastatic non-small cell lung cancer: a significant entity outside of specialized cancer centers? Med Princ Pract 2014;23:526–531. doi:10.1159/000365634. PMID:25196201.
   PubMed Web of Science ®Google Scholar
• Thunnissen E, van der Oord K, den Bakker M. Prognostic and predictive biomarkers in lung cancer. A review. Virchows Arch 2014;464:347–358. doi:10.1007/s00428-014-1535-4.
   PubMed Web of Science ®Google Scholar
• Lehman, M. Improving therapeutic outcomes in non-small cell lung cancer not suitable for curative intent therapy – A review of the role of radiation therapy in an era of increasing systemic therapy options. Clin Oncol (R Coll Radiol) 2016;28:327–333. doi:10.1016/j.clon.2015.11.015. PMID:26777130.
   PubMed Web of Science ®Google Scholar
• Stevens R, Macbeth F, Toy E, Coles B, Lester JF. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer. Cochrane Database Syst Rev 2015;1:CD002143. PMID:25586198.
   PubMedGoogle Scholar
• Giaj-Levra N, Ricchetti F, Alongi F. What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review. Cancer Invest 2016;34:80–93. doi:10.3109/07357907.2015.1114121.
   PubMed Web of Science ®Google Scholar
• Erridge SC, Gaze MN, Price A, Kelly CG, Kerr GR, Cull A, MacDougall RH, Howard GC, Cowie VJ, Gregor A, et al. Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) 2005;17:61–67. doi:10.1016/j.clon.2004.09.008. PMID:15714933.
   PubMed Web of Science ®Google Scholar